Lorcaserin: Difference between revisions

Jump to navigation Jump to search
(#REDIRECT #REDIRECT #REDIRECT)
 
(29 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{CMG}}
#REDIRECT [[Lorcaserin Hydrochloride Hemihydrate]]
==Overview==
Lorcaserin is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an [[anorectic]].  On 27 June 2012, the FDA officially approved lorcaserin for use in the treatment of obesity for adults with a BMI equal to or greater than 30 or adults with a BMI of 27 or greater who "have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol".
 
==References==
{{Reflist|2}}
 
{{WH}}
{{WS}}

Latest revision as of 21:29, 14 January 2015